Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A mitochondrial oxidative phosphorylation uncoupler is a molecule that disrupts the normal coupling between the electron transport chain (ETC) and ATP synthesis in mitochondria, leading to increased oxygen consumption and heat production, while reducing or halting ATP synthesis. Uncouplers act primarily by transporting protons across biological membranes, bypassing ATP synthase, ultimately reducing efficiency of oxidative phosphorylation. Endogenous uncoupling proteins also mediate regulated physiological uncoupling for thermogenesis or protection against reactive oxygen species.
Dissipates proton gradient across the inner mitochondrial membrane, bypassing ATP synthase and uncoupling electron transport from ATP synthesis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Oxidative Phosphorylation Uncoupler (Uncoupler).